Literature DB >> 19704132

Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.

Ricardo Araujo1, Ana Espinel-Ingroff.   

Abstract

Posaconazole MICs for 50 Aspergillus fumigatus isolates with distinct genotypes were determined by three methods. MICs were > or = 0.5 microg/ml for 5, 11, and 15 strains by the CLSI reference M38-A2, Etest (48-h), and oxygen consumption methods, respectively. The levels of categorical agreement between the results obtained by the CLSI method and those obtained by the oxygen consumption and Etest methods were 80 and 84%, respectively.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19704132      PMCID： PMC2772333          DOI： 10.1128/AAC.00862-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.

Authors:  A J De Lucca; T J Walsh; D J Daigle
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.

Authors:  Ana Espinel-Ingroff; A Rezusta
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.

Authors:  E Chryssanthou; M Cuenca-Estrella
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

4.  Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species.

Authors:  Charalampos Antachopoulos; Joseph Meletiadis; Tin Sein; Emmanuel Roilides; Thomas J Walsh
Journal:  J Antimicrob Chemother       Date:  2006-12-21       Impact factor: 5.790

5.  Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.

Authors:  A L Barry; M A Pfaller; S D Brown; A Espinel-Ingroff; M A Ghannoum; C Knapp; R P Rennie; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.

Authors:  M A Pfaller; S A Messer; L Boyken; R J Hollis; D J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2003-04       Impact factor: 2.803

Review 7.  Posaconazole: an extended-spectrum triazole antifungal agent.

Authors:  Daryl S Schiller; Horatio B Fung
Journal:  Clin Ther       Date:  2007-09       Impact factor: 3.393

8.  Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.

Authors:  Paul A Mann; Raulo M Parmegiani; Shui-Qing Wei; Cara A Mendrick; Xin Li; David Loebenberg; Beth DiDomenico; Roberta S Hare; Scott S Walker; Paul M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

9.  In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

Authors:  C Lass-Flörl; G Kofler; G Kropshofer; J Hermans; A Kreczy; M P Dierich; D Niederwieser
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

10.  Simple and highly discriminatory microsatellite-based multiplex PCR for Aspergillus fumigatus strain typing.

Authors:  R Araujo; C Pina-Vaz; A G Rodrigues; A Amorim; L Gusmão
Journal:  Clin Microbiol Infect       Date:  2009-01-22       Impact factor: 8.067
View more
  7 in total

1.  In Vitro Susceptibility of Fusarium to Isavuconazole.

Authors:  A Broutin; J Bigot; Y Senghor; A Moreno-Sabater; J Guitard; C Hennequin
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant Aspergillus Section Fumigati Clinical Isolates.

Authors:  S Dellière; L Verdurme; J Bigot; E Dannaoui; Y Senghor; F Botterel; A Fekkar; M E Bougnoux; C Hennequin; J Guitard
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 3.  Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.

Authors:  R Araujo; M Oliveira; A Amorim; B Sampaio-Maia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

4.  Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.

Authors:  Frédéric Lamoth; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

Review 5.  Invasive aspergillosis: resistance to antifungal drugs.

Authors:  Inès Hadrich; Fattouma Makni; Sourour Neji; Salma Abbes; Fatma Cheikhrouhou; Houaida Trabelsi; Hayet Sellami; Ali Ayadi
Journal:  Mycopathologia       Date:  2012-02-11       Impact factor: 2.574

6.  (New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples.

Authors:  Jeffrey D Jenks; Birgit Spiess; Dieter Buchheidt; Martin Hoenigl
Journal:  Curr Fungal Infect Rep       Date:  2019-06-20

Review 7.  Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.

Authors:  Eric Dannaoui; Ana Espinel-Ingroff
Journal:  J Fungi (Basel)       Date:  2019-11-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.